Invesco’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
143,445
+58,085
| +68% | +$652K | ﹤0.01% | 2652 |
|
|
2025
Q1 | $390K | Buy |
85,360
+28,220
| +49% | +$129K | ﹤0.01% | 3240 |
|
|
2024
Q4 | $322K | Buy |
57,140
+3,080
| +6% | +$17.4K | ﹤0.01% | 3376 |
|
|
2024
Q3 | $262K | Sell |
54,060
-971
| -2% | -$4.7K | ﹤0.01% | 3437 |
|
|
2024
Q2 | $269K | Sell |
55,031
-2,131
| -4% | -$10.4K | ﹤0.01% | 3523 |
|
|
2024
Q1 | $759K | Buy |
57,162
+31,144
| +120% | +$414K | ﹤0.01% | 3114 |
|
|
2023
Q4 | $363K | Buy |
26,018
+5,860
| +29% | +$81.7K | ﹤0.01% | 3363 |
|
|
2023
Q3 | $267K | Sell |
20,158
-101
| -0.5% | -$1.34K | ﹤0.01% | 3485 |
|
|
2023
Q2 | $380K | Sell |
20,259
-1,822
| -8% | -$34.2K | ﹤0.01% | 3380 |
|
|
2023
Q1 | $318K | Buy |
22,081
+5,823
| +36% | +$84K | ﹤0.01% | 3460 |
|
|
2022
Q4 | $315K | Sell |
16,258
-148,918
| -90% | -$2.88M | ﹤0.01% | 3470 |
|
|
2022
Q3 | $5.67M | Buy |
165,176
+152,057
| +1,159% | +$5.22M | ﹤0.01% | 2149 |
|
|
2022
Q2 | $201K | Buy |
13,119
+3,220
| +33% | +$49.3K | ﹤0.01% | 3698 |
|
|
2022
Q1 | $226K | Buy |
9,899
+2,606
| +36% | +$59.5K | ﹤0.01% | 3711 |
|
|
2021
Q4 | $269K | Buy |
7,293
+2,024
| +38% | +$74.7K | ﹤0.01% | 3624 |
|
|
2021
Q3 | $248K | Buy |
+5,269
| New | +$248K | ﹤0.01% | 3687 |
|